Do you have experience in Rare Diseases and a passion to make an impact for patients? Are you ready to take on a pivotal role leading medical affairs across the Nordics?
Haeger & Carlsson Executive Search and Interim is supporting Italfarmaco’s Rare Diseases Cluster Nordics in the recruitment of a Nordic Medical Affairs Director.
This is a business-critical leadership role that will shape the future of Italfarmaco Rare Diseases in the region. You will lead and oversee all medical-scientific activities across the Nordic cluster, ensuring the effective execution of Italfarmaco’s Rare Disease strategy with an initial focus on Duchenne Muscular Dystrophy (DMD). The role combines strategic vision with hands-on execution and requires a strong scientific mindset and a proactive, solution-oriented approach.
You will manage a team of field-based Medical Liaison Managers, drive the implementation of the European medical strategy locally, and as a member of the cross-functional leadership team collaborate closely with Market Access and Regulatory Affairs to support reimbursement processes as well as collaborate with the Commercial team to ensure patient access in the Nordic region. Building strong relationships with Key Opinion Leaders and external stakeholders will be essential, as will ensuring compliance with international and local regulations, as well as establishing a string internal network within Global Medical, R&D and Medical teams across Europe.
We are looking for a prestige-free, energetic professional with strong personal drive, flexibility, and a “can-do” attitude, someone who thrives on collaboration, embraces travel, and enjoys working where science meets strategy. You combine strategic thinking with a hands-on approach, build strong external networks quickly, and understand the complexities of market access in the Nordic healthcare landscape. Ideally, you bring previous experience in rare diseases or rare indications in the Nordics, as well as leadership experience or a strong motivation to step into a leadership role.
About the company
Founded in 1938 in Milan, Italy, Italfarmaco S.p.A is a private global pharmaceutical company that has led the successful development and approval of many pharmaceutical products around the world. Italfarmaco S.p.A. currently employs 3,500 people and has operations in more than 60 countries through directly controlled or affiliated companies. The company is a leader in pharmaceutical research, product development, production and commercialization with proven success in many therapeutic areas including immuno-oncology, gynecology, neurology, cardiovascular disease and rare diseases. Italfarmaco's rare disease unit includes programs in Duchenne muscular dystrophy, Becker muscular dystrophy, amyotrophic lateral sclerosis and polycythaemia vera.
Italfarmaco Nordics was established late 2023, and in this role, you will contribute to the shaping of the company within Rare Disease in the region. The corporate culture in the Nordics emphasizes drive, entrepreneurship, and strong determination to make a difference for people living with rare diseases.
Read more: https://www.italfarmaco.se/
Key responsibilities
Education & experience
The role reports to Head of Rare Disease Cluster with a dotted line to Medical Affairs Lead Rare Disease Europe and is based in Sweden, Denmark or Norway.
If you are passionate about advancing science in Rare Diseases and want to make a tangible impact on patients’ lives, this is your opportunity to join a dynamic organization with an exciting pipeline. We look forward to your application.
Please apply through www.haegercarlsson.com
Questions are answered by
Anna Freese +46(0)76-174 75 81, anna.f@haegercarlsson.com